Skorpios Trust - 04 Jun 2025 Form 4 Insider Report for Stoke Therapeutics, Inc. (STOK)

Reporting relationship: 10%+ Owner
Issuer ticker: STOK
Reported as of: 04 Jun 2025
Net transaction value: -$30,600,000
SEC form: 4
Accepted by SEC: 06 Jun 2025, 16:20:31 UTC
Prior SEC filing: 27 Dec 2024
Source filing: View source filing
Reporting owner signature: /s/ Androulla Papadopoulou, Authorized Signatory on behalf of Skorpios Trust

Key filing fact

Skorpios Trust filed Form 4 for Stoke Therapeutics, Inc. (STOK) on 06 Jun 2025.

Key facts

This page summarizes Skorpios Trust's Form 4 filing for Stoke Therapeutics, Inc. (STOK).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 06 Jun 2025, 16:20.

Change

Previous filing in this sequence was filed on 27 Dec 2024.
Current net transaction value: -$30,600,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (4)

CIK 0001869333 Primary reporting owner

Skorpios Trust

Relationship: 10%+ Owner
Address: 195 ARCH. MAKARIOS III AVE., NEOCLEOUS HOUSE, LIMASSOL, CYPRUS
Signature: /s/ Androulla Papadopoulou, Authorized Signatory on behalf of Skorpios Trust
Signature date: 06 Jun 2025

CIK 0001869057

Blue Horizon Enterprise Ltd

Relationship: 10%+ Owner
Address: 195 ARCH. MAKARIOS III AVE., NEOCLEOUS HOUSE, LIMASSOL, CYPRUS
Signature: /s/ Eleni Constantinou Kyriacou, Authorized Signatory on behalf of Blue Horizon Enterprises Ltd.
Signature date: 06 Jun 2025

CIK 0001869027

Ezbon International Ltd

Relationship: 10%+ Owner
Address: 195 ARCH. MAKARIOS III AVE., NEOCLEOUS HOUSE, LIMASSOL, CYPRUS
Signature: /s/ Eleni Constantinou Kyriacou, Authorized Signatory on behalf of Ezbon International Limited
Signature date: 06 Jun 2025

CIK 0001869331

Montrago Trustees Ltd

Relationship: 10%+ Owner
Address: 195 ARCH. MAKARIOS III AVE, NEOCLEOUS HOUSE, LIMASSOL, CYPRUS
Signature: /s/ Androulla Papadopoulou, Authorized Signatory on behalf of Montrago Trustees Limited
Signature date: 06 Jun 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

STOK transaction

Common Stock

Sale

Transaction value: $30,600,000
Shares: -3,000,000
Change %: -43%
Price: $10.20
Shares after: 3,906,181
Date: 04 Jun 2025
Ownership: See Footnote
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Skorpios Trust is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 1 footnote

Footnote F1

Blue Horizon Enterprise Ltd. ("Blue Horizon") is the direct owner of 2,967,621 shares of the issuer's common stock and Ezbon International Limited ("Ezbon") is the direct owner of 938,560 shares of the issuer's common stock. Skorpios Trust ("Skorpios") is the sole owner of each of Blue Horizon and Ezbon. Montrago Trustees Limited ("Montrago Trustees") is the corporate trustee of Skorpios Trust. Each of Blue Horizon and Ezbon disclaim beneficial ownership of the shares of the issuer's common stock held by the other, and each of Skorpios Trust and Montrago Trustees disclaim beneficial ownership of the issuer's securities except to the extent of their pecuniary interest therein.